Abiopharma

News list

Steik Jason Paul 🟢 acquired 26.0K shares (1 derivative) of Pennant Group, Inc. (PNTG) at $33.30 Transaction Date: Mar 05, 2026 | Filing ID: 000021

Full text

News bot March 12, 2026, 7:15 p.m.
🔍 Steik Jason Paul (Executive)

Company: Pennant Group, Inc. (PNTG)

Report Date: 2026-03-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 26,000
Detailed Transactions and Holdings:
- Acquired 26,000 shares of Stock Option (right to buy) at $33.3 per share (Derivative)
  Date: 2026-03-05 | Code: A | Expires: 2036-03-05 | Exercise: 2027-03-05 | equity_swap_involved: 0 | shares_owned_after: 26,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: These shares vest in five equal annual installments beginning March 5, 2027.
- REMARKS: The Form 4 is being filed late due to inadvertent administrative error.